RNA fluorescent probe for rapidly distinguishing cancer tissue from normal tissue based on nucleolar morphological changes

Patent metadata

Field	Value
Publication number	US-12435268-B2
Application number	US-202017606271-A
Country	US
Kind code	B2
Filing date	Dec 3, 2020
Priority date	Jul 22, 2020
Publication date	Oct 7, 2025
Grant date	Oct 7, 2025

Abstract

An RNA fluorescent probe for rapidly distinguishing cancer tissue from normal tissue based on nucleolar morphological changes, the probe being (E)-1-(3-aminopropyl)-4-(2-(9-ethyl-9H-carbazol-3-yl)vinyl)pyridine-1-ium dibromide, abbreviated as CAPY-AP. The probe can target RNA in culture cells and normal tissue as well as cancer tissue and then display nucleolar morphology. The judging criteria of distinguishing the cancer tissue from the normal tissue based on the nucleolar morphological changes is only single and unconspicuous nucleolus in most cells of normal tissue, while the enlarged nucleoli and/or multiple nucleoli exist in many cells of cancer tissue. Compared with other existing RNA probes, the probe has super-high RNA affinity and super-high permeability, and can rapidly image the RNA and nucleoli in tissue sections. Additionally, the probe has characteristics of good membrane permeability, strong fluorescence and good photostability, and is expected to be applied in preparation of intraoperative pathological diagnostic reagents for tumors.

First claim

What is claimed is:

1. An RNA fluorescent probe for rapidly distinguishing cancer tissue from normal tissue, wherein a chemical name of the RNA fluorescent probe is (E)-1-(3-aminopropyl)-4-(2-(3-(9-ethyl-carbazol))vinyl)pyridine dibromide salt, abbreviated as CAPY-AP; a chemical structure of the RNA fluorescent probe is shown in formula (I):

2. A method for tissue processing and analysis using the RNA fluorescent probe according to claim 1 , comprising:
(1) applying the RNA fluorescent probe to a tissue section, wherein the probe binds to RNA in the tissue to form fluorescent labeling;
(2) using fluorescence microscopy to observe the treated tissue section and obtain fluorescence images showing nucleolar size and nucleolar number of cells; and
(3) determining tissue characteristics based on the nucleolar size and nucleolar number observed in the obtained fluorescence images, wherein cancer tissue is identified by comparing cells in cancer tissue with cells in normal tissue, with cancer cells exhibiting multiple nucleoli and/or increased nucleolar size.

3. A method for preparing the RNA fluorescent probe for rapidly distinguishing cancer tissue from normal tissue according to claim 1 , comprising the steps of firstly mixing 4-methylpyridine with 3-bromopropylamine hydrobromide to react to obtain compound 1; performing a Vilsmeier reaction to synthesize compound 2; mixing compound 1 and compound 2 to prepare a final product by a reflux reaction with piperidine as a catalyst; and finally obtaining a purified red solid product CAPY-AP by column chromatography, wherein the structures of compound 1 and compound 2 are as follows:

4. A method for rapid staining cultured cells, wherein the method comprises staining cells with the RNA fluorescent probe of claim 1 , labeling or displaying distributions of RNA and nucleoli in the cells.

5. The method according to claim 4 , wherein the cells are cancer cells or normal cells.

6. A method for rapidly distinguishing cancer tissue from normal tissue, wherein the method comprises staining all cells in a tissue section with the RNA fluorescent probe of claim 1 , labeling or displaying distributions of RNA and nucleoli in all cells.

7. The method of claim 6 , wherein the tissue section is a normal tissue section or a pathological section.

8. The method of claim 6 , wherein the tissue section is a tissue section of mammary gland.

9. The method of claim 6 , wherein judging criteria of distinguishing the cancer tissue from the normal tissue are that there is only single and unconspicuous nucleolus in most cells of normal tissue, while the enlarged nucleoli and/or multiple nucleoli exist in many cells of cancer tissue.

10. A rapid pathological diagnostic reagent for rapidly distinguishing cancer tissue from normal tissue, comprising the RNA fluorescent probe according to claim 1 .

Assignees

• Univ Shandong

Inventors

• Yu Xiaoqiang
• Gao Peng
• He Xiuquan
• Meng Fangfang
• He Junyi
• Liu Zhiqiang

Classifications

• G01N33/57595

  involving intracellular compounds · CPC title

• G01N2021/6439

  with indicators, stains, dyes, tags, labels, marks · CPC title

• G01N2001/302

  Stain compositions · CPC title

• G01N33/582

  with fluorescent label · CPC title

• G01N21/6428

  Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53) · CPC title